Results for tag: "T Cell Surface Glycoprotein CD4"

The T Cell Surface Glycoprotein CD4 market is a subset of the oncology drugs market. CD4 is a glycoprotein found on the surface of T cells, which are a type of white blood cell that plays a role in the body's immune system. CD4 is used to measure the number of T cells in the body, and is used to diagnose and monitor HIV/AIDS. It is also used to monitor the effectiveness of treatments for HIV/AIDS and other immune-related diseases. CD4 is also used to diagnose and monitor certain types of cancer, such as lymphoma and leukemia. The CD4 market is driven by the increasing prevalence of HIV/AIDS and other immune-related diseases, as well as the increasing demand for more effective treatments for these diseases. The market is also driven by the increasing prevalence of cancer, as well as the need for more accurate diagnosis and monitoring of cancer. Companies in the CD4 market include AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more